FILE - A sign for the U.S. Food and Drug Administration is displayed outside their offices in Silver Spring, Md., Dec. 10, 2020. U.S. health regulators on Monday, July 29, 2024, approved a ...

Add Yahoo as a preferred source to see more of our stories on Google. WASHINGTON (DC News Now) — A new blood test may make it much easier and cheaper to screen for signs of colon cancer. Test ...

MINNEAPOLIS — A possible medical game-changer as the FDA approves a new blood test for colon cancer. On Monday, the Food and Drug Administration approved Guardant Health's blood test called 'Shield.' ...

For adults with average cancer risk, a blood test could provide an option for colon cancer screening instead of a colonoscopy. The Food and Drug Administration has approved a blood test, Shield, that ...

The U.S. Preventive Services Task Force recommends colorectal cancer screening for all adults starting at age 45. After age 75, the task force recommends talking with your health care team to decide ...

Screening for the second leading cause of cancer deaths just got a bit easier. The U.S. Food and Drug Administration (FDA) announced the approval of a new blood test for colorectal cancer (CRC).

For years, a diagnosis of colon cancer meant potential surgery followed by a painful round of chemotherapy to kill the remaining cancer cells. One-size-fits-all treatment was normal. A new blood test ...

The FDA has approved a new blood test that can be used to detect colon cancer. Doctors say this blood test can reduce the number of colonoscopies and increase screening rates. TULSA, Okla. - The FDA ...

Breakthroughs, discoveries, and DIY tips sent six days a week. Terms of Service and Privacy Policy. The United States Food and Drug Administration (FDA) approved a ...

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. WASHINGTON (AP) — U.S. health regulators on ...

This week, the FDA approved a blood test for colorectal cancer that the medical community feels could save lives. The test, called Shield, is expected to greatly increase the number of people willing ...